Jade Biosciences, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +12.0% | +0.0% | +0.0% | +678.6% | -96.3% | -50.0% | -75.0% | +1,100.0% | -25.0% | +0.0% | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5.5% | +12.7% | +5.8% | -36.1% | -88.7% | +1,207.8% | +12.6% | -2.4% | +29.7% | +26.3% | +38.9% | – | |
| – | – | – | – | – | +74.0% | +39.6% | +55.6% | +3.1% | +17.6% | +16.6% | +19.7% | – | |
| – | +3.3% | +11.6% | +6.3% | -42.7% | -57.3% | -47.1% | +721.1% | -1.4% | +27.7% | +24.2% | +35.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -72.4% | -6.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.